Rheum Cat rheum_cat
3 years 1 month ago
OA oral session - abstract 1904
Devin Driscoll (mentor @tuhina_neogi) presenting data from MOST:
Evaluation of Neuropathic-like Symptoms and Objective Signs of Neuropathy Post-Knee Replacement
#ACR21 https://t.co/APZAJdHH5M
Didem Saygin, MD didemsayginmd
3 years 1 month ago
Dr Ami Shah - Scleroderma & Cancer:
🛑 ⬆️ risk of ca around the time of dx in SSc patients with RNA-pol-III (especially first 5 years after dx), anti-Th/To protective?
🛑Her approach for ca screening in newly diagnosed with SSc pts and red flags as below
#ACR21 #ACRambassador https://t.co/2VcWn2UInm
Janet Pope Janetbirdope
3 years 1 month ago
IL17 IS Impt in giant cell arthritis. Who would’ve thought that #secukinumab would treat #GCA? More options for pts. Only 52 pts but maybe another Rx for GCA? #ACR21 abst#L19 https://t.co/dwbPmGswQ9
Dr Irwin Lim _connectedcare
3 years 1 month ago
Hair Loss due to Methotrexate from RCTs in RA estimated at 6.9%.
It's an understandable source of concern for those taking the medication
#ACR21 https://t.co/GymV2RC7jT
Vaneet K Sandhu, MD (she/her/hers) vksandhumd
3 years 1 month ago
@ashira_md blazing through again! Tune in now to hear her talk on #microaggressions and #gaslighting
#ACR21 #ACRAmbassador #DEI https://t.co/uqvLxxcs43
Laurent ARNAUD Lupusreference
3 years 1 month ago
🆕 Main findings of #Lupus trials presented at #ACR21 ⬇️ https://t.co/HENxcyLuf5
Herman Tam DrPedsRheum
3 years 1 month ago
🗳️Poll of the day for #ACR21 #ACRambassador
@ACRheum
🤔What format do you prefer for #ACR22?
Veena Katikineni VeenaRheumMD
3 years 1 month ago
Dr. Lane on Ca/Vitamin D in Osteoporosis
⭐️🎯serum vitamin D 25OH ~38
⭐️Studies since 2008 Auckland Calcium trial DO NOT support incr CV risk with Ca supplementation
⭐️Ca calculator: https://t.co/PLPMfZdIwb
⭐️No sig change in fracture risk with supp
#ACR21 #ACRAmbassador https://t.co/KUa52vf4gT
Veena Katikineni VeenaRheumMD
3 years 1 month ago
Dr. Fiorentino on cancer risk stratification and screening in myositis. Come chat at noon in the Myositis Community Hub to learn more!
#ACR21 #ACRAmbassador https://t.co/I0iQuPAuOl
Vaneet K Sandhu, MD (she/her/hers) vksandhumd
3 years 1 month ago
Thanks Dr David Fiorentino for his talk on CA and myositis!
⬆️risk:
- DM
- >45-50yo
- males
- TIF1-gamma Ab (4.7RR of CA)
- NXP2
- low CK
- dysphagia
⬇️ risk:
- synthetase Ab
- raynaud
- ILD
- inflamm arth
🚨TIF1-gamma🚨
- ovarian CA (older, IgG2)
#ACR21 #ACRAmbassador
Vaneet K Sandhu, MD (she/her/hers) vksandhumd
3 years 1 month ago
Risk Stratification for CA in IIM
Low risk:
- no clin RF + at least 1 protective factor
- autoAb (Jo1, Mi2, MDA5,SRP,RNP/SSA/SSB)
Intmdt risk:
- 1-2 clin RF
- auto Ab (SAE1, HMGCR)
- PM/INMN no Ab
Hi riks:
- >2 clin RF
- h/o CA
- autoAb (TIF1g, NXP2)
#ACR21 #ACRAmbassador https://t.co/nTBSDcS1v4
Vaneet K Sandhu, MD (she/her/hers) vksandhumd
3 years 1 month ago
Screening for CA in IIM:
Low risk:
* CXR, age approp CA screen
Intmdt risk:
* CT c/a/p, tm mrkrs (CA125♀️, PSA♂️), pelvic US, colo <50yo, mammo <50>75)
Hi risk (?annually):
* whole body PET-CT
When?
Annual x hi risk?
Recalcitrant /Unexpl flare
#ACR21 #ACRAmbassador
Dr. Laura Lewandowski LauraLewMad11
3 years 1 month ago
#ACR21 #pedsrheum
I say it counts!
I mean, at the end of the day, these are all just pictures of food on the internet, right?
#ACRBakeAnythingChallenge https://t.co/bVQuealWWX
Pedro Castillo _Castillo_Pedro
3 years 1 month ago
Dr. Melissa Munroe - Lupus Classification Risk Immune Index
🔹Pre-/post-classification serum
🔹Avg time➡️classification 4.7y
🔹9 immune mediators altered in pre-clinical dz
🔹Pos score = ⬆️likelihood➡️SLE; Neg = ⬇️
https://t.co/UFEkGieXum
1/2
#ACR21 Abst#1423 @RheumNow #ACRBest
Dr. Rachel Tate uptoTate
3 years 1 month ago
Late breaking, but just in time! mRNA COVID-19 3rd dose in RTX pts, w/o Ab response post initial series. After 3rd dose many had ab response or T cell response.
Extra vaccine full doses can protect RTX pts from COVID! AbsL17 #ACRbest #ACR21 @RheumNow https://t.co/lIDPzybmT7 https://t.co/jEJ3N6cdjK